1. Home
  2. SWAG vs GNTA Comparison

SWAG vs GNTA Comparison

Compare SWAG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stran & Company Inc.

SWAG

Stran & Company Inc.

HOLD

Current Price

$1.86

Market Cap

36.9M

ML Signal

HOLD

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.93

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWAG
GNTA
Founded
1994
2014
Country
United States
Italy
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.9M
39.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SWAG
GNTA
Price
$1.86
$1.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
696.5K
136.9K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$114,242,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.34
N/A
52 Week Low
$0.73
$1.35
52 Week High
$3.50
$10.00

Technical Indicators

Market Signals
Indicator
SWAG
GNTA
Relative Strength Index (RSI) 44.60 41.39
Support Level $1.81 $1.35
Resistance Level $2.10 $2.20
Average True Range (ATR) 0.33 0.23
MACD -0.07 0.04
Stochastic Oscillator 10.44 58.76

Price Performance

Historical Comparison
SWAG
GNTA

About SWAG Stran & Company Inc.

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: